Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

August 2013 - FRMC

Foam Approved for Acne Vulgaris - Fabior™ (tazarotene) Foam, 0.1%
08/15/2013
The FDA approved tazarotene foam for acne vulgaris based on the results of two, phase 3 studies conducted in the US and Canada. 
The FDA approved tazarotene foam for acne vulgaris based on the results of two, phase 3 studies conducted in the US and Canada. 
The FDA approved tazarotene foam...
08/15/2013
First Report Managed Care
Omacetaxine Mepesuccinate for Chronic Myeloid Leukemia
08/15/2013

Tori Socha

Tori Socha
Chicago—Of patients with chronic myeloid leukemia (CML) who are treated with tyrosine-kinase inhibitors (TKIs), 20% to 30% develop resistance to the drugs; others are intolerant.
Chicago—Of patients with chronic myeloid leukemia (CML) who are treated with tyrosine-kinase inhibitors (TKIs), 20% to 30% develop resistance to the drugs; others are intolerant.
Chicago—Of patients with chronic...
08/15/2013
First Report Managed Care
Nivolumab to Treat Advanced Melanoma
08/15/2013

Tim Casey

Tim Casey
Chicago—After 2 years of treatment, 43% of patients with advanced melanoma who received nivolumab were alive, according to a phase 1 study. The 1-year overall survival rate was 62%, and median overall survival was 16.8 months. All patients...
Chicago—After 2 years of treatment, 43% of patients with advanced melanoma who received nivolumab were alive, according to a phase 1 study. The 1-year overall survival rate was 62%, and median overall survival was 16.8 months. All patients...
Chicago—After 2 years of...
08/15/2013
First Report Managed Care
Patient-Reported Outcomes in Patients with Multiple Myeloma
08/15/2013

Tori Socha

Tori Socha
Chicago—A broad perspective of disease burden and impact of treatment may be gained utilizing patient-reported outcomes (PROs) such as health-related quality of life (HRQoL). For patients with multiple myeloma (MM) and other hematologic...
Chicago—A broad perspective of disease burden and impact of treatment may be gained utilizing patient-reported outcomes (PROs) such as health-related quality of life (HRQoL). For patients with multiple myeloma (MM) and other hematologic...
Chicago—A broad perspective of...
08/15/2013
First Report Managed Care
Lenvatinib for Advanced BRAF Wild-Type Melanoma
08/15/2013

Tim Casey

Tim Casey
Chicago—At a minimum of 15 months follow-up, patients with unresectable, metastatic BRAF wild-type melanoma who received 24 mg of lenvatinib once daily had a median progression-free survival of 3.7 months and a median overall survival of 9.5...
Chicago—At a minimum of 15 months follow-up, patients with unresectable, metastatic BRAF wild-type melanoma who received 24 mg of lenvatinib once daily had a median progression-free survival of 3.7 months and a median overall survival of 9.5...
Chicago—At a minimum of 15...
08/15/2013
First Report Managed Care
Survey on Oncology Drug Shortages
08/15/2013

Tim Casey

Tim Casey
Chicago—According to a survey, most oncologists and hematologists have faced drug shortages in recent years and have had to deny, delay, or modify treatment regimens for cancer patients. Although the scarcity of these drugs has received...
Chicago—According to a survey, most oncologists and hematologists have faced drug shortages in recent years and have had to deny, delay, or modify treatment regimens for cancer patients. Although the scarcity of these drugs has received...
Chicago—According to a survey,...
08/15/2013
First Report Managed Care
Butrans® (buprenorphine) Transdermal System and Chronic Low Back Pain
08/15/2013

Tim Casey

Tim Casey
Patients with moderate-to-severe chronic low back pain who received 12 weeks of treatment with the Butrans® (buprenorphine) transdermal system had significant improvements in several activities of daily living compared with a placebo group.
Patients with moderate-to-severe chronic low back pain who received 12 weeks of treatment with the Butrans® (buprenorphine) transdermal system had significant improvements in several activities of daily living compared with a placebo group.
Patients with moderate-to-severe...
08/15/2013
First Report Managed Care
Opioid Usage and Diabetic Peripheral Neuropathy
08/15/2013

Tim Casey

Tim Casey
An analysis of a claims database found that 61% of patients with diabetic peripheral neuropathy had not received treatment for the disease.Although if patients took medications, they typically used opioids to manage the condition.
An analysis of a claims database found that 61% of patients with diabetic peripheral neuropathy had not received treatment for the disease.Although if patients took medications, they typically used opioids to manage the condition.
An analysis of a claims database...
08/15/2013
First Report Managed Care
Linaclotide for Treatment of IBS-C and Chronic Constipation
08/15/2013

Tori Socha

Tori Socha
There are limited options available for the treatment of irritable bowel syndrome with constipation, but linaclotide has recently been approved.
There are limited options available for the treatment of irritable bowel syndrome with constipation, but linaclotide has recently been approved.
There are limited options...
08/15/2013
First Report Managed Care

Department

Conference Insider
Value-Based Healthcare
08/15/2013

Tim Casey

Tim Casey
Fort Lauderdale—In the United States, approximately 100 million adults have chronic pain, which is associated with $275 billion in healthcare costs and $300 billion in lost worker productivity each year. The combined costs are larger than...
Fort Lauderdale—In the United States, approximately 100 million adults have chronic pain, which is associated with $275 billion in healthcare costs and $300 billion in lost worker productivity each year. The combined costs are larger than...
Fort Lauderdale—In the United...
08/15/2013
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 2

Current Issue

June 2024
Volume 21
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

Department
“Smart Pill-Bottle” Significantly Improves Medication Adherence
10/20/2016
Research showed that use of a “smart pill-bottle,” which provides additional reminders and instructions to patients, increased medication adherence.
Research showed that use of a “smart pill-bottle,” which provides additional reminders and instructions to patients, increased medication adherence.
Research showed that use of a...
10/20/2016
First Report Managed Care
News
Home health stocks crash on criminal probe speculation
10/13/2011
10/13/2011
First Report Managed Care
News
Gastric Bypass Offers GERD Benefits, Too
02/02/2015
In addition to causing significant weight loss, gastric bypass surgery appears to significantly reduce gastroesophageal reflux disease symptoms and incidence in morbidly obese individuals long after the procedure.
In addition to causing significant weight loss, gastric bypass surgery appears to significantly reduce gastroesophageal reflux disease symptoms and incidence in morbidly obese individuals long after the procedure.
In addition to causing...
02/02/2015
First Report Managed Care
News
Gains in Multiple Myeloma Survival Outpace Costs
09/11/2018
Patients recently diagnosed with multiple myeloma are incurring greater healthcare costs compared with patients diagnosed just a few years earlier, however, those additional dollars spent coincide with substantial gains in survival, according...
Patients recently diagnosed with multiple myeloma are incurring greater healthcare costs compared with patients diagnosed just a few years earlier, however, those additional dollars spent coincide with substantial gains in survival, according...
Patients recently diagnosed with...
09/11/2018
First Report Managed Care
News
Lawmakers say Glaxo hid Avandia risks
07/14/2010
07/14/2010
First Report Managed Care

Video Insights

Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

August 2013 Volume 10 Issue 8

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement